Information Provided By: 
Fly News Breaks for November 23, 2016
MDT
Nov 23, 2016 | 07:30 EDT
UBS analyst Matt Miksic lowered his price target on Medtronic to $88 from $96 following Q2 results. The analyst said the company's top-line miss was driven by unrelated and temporary issues and he sees the long-term growth model intact and expects mid-single growth in the second half of 2017. Miksic reiterated his Buy rating on Medtronic shares.
News For MDT From the Last 2 Days
There are no results for your query MDT
